MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Clinical Features and Treatment Response in Stiff Person Spectrum Disorder: A Case Series from a Tertiary Neurology Centre

    A. Oommen, P. Wadia (Mumbai, India)

    Objective: To describe the clinical features, electrophysiological findings, and treatment outcomes of patients with Stiff Person Spectrum Disorder (SPSD) evaluated at a tertiary neurology centre.…
  • 2026 International Congress

    Accelerated brain iron accumulation secondary to hypoxia in a patient with hereditary haemochromatosis with homozygous C282Y mutations.

    A. Chakraborty, D. Gallagher, C. Simonet, N. Gorgoraptis (London, United Kingdom)

    Objective: To describe the case of a 60-year-old male with a diagnosis of Hereditary Haemochromatosis (HHE) with homozygous C282Y mutations presenting with progressive parkinsonism, cognitive…
  • 2026 International Congress

    Levodopa-Induced Dyskinesias in Patients with Parkinson’s Disease in the Uzbek Population

    G. Isroilova, Z. Sayfitdinkhuzhaev (Tashkent, Uzbekistan)

    Objective: To investigate the clinical features and prevalence of levodopa-induced dyskinesias in patients with Parkinson’s disease in the Uzbek population. Background: Levodopa-induced dyskinesias (LID) are…
  • 2026 International Congress

    Global Performance Patterns in the MDS-UPDRS Motor Certification Program: A five-year Analysis

    C. Falup-Pecurariu, C. Akbostanci, E. Bayram, I. Estrada-Bellmann, J. Ma, T. Mestre, I. Murasan, O. Ojo, P. Pal, M. Qamar, F. Rodriguez-Porcel, A. Sanchez Ferro (Brasov, Romania)

    Objective: To evaluate participation trends, certification rates, case-level difficulty, and item-level performance patterns over five years. Background: The MDS-UPDRS Part III is a core outcome…
  • 2026 International Congress

    The Prevalence of Parkinson’s Disease in Kilifi County, Kenya: A ‘Transforming Parkinson’s Care in Africa’ (TraPCAf) study

    R. Morton, S. Mwamba, D. Nyabuto, S. Kariuki, A. Nyaguara, J. Nambafu, M. Atieno, D. Sokhi, M. Cham, S. Urasa, N. Okubadejo, O. Ojo, Y. Okkaoglu, C. Dotchin, N. Fothergill-Misbah, C. Newton, R. Walker (Newcastle Upon Tyne, United Kingdom)

    Objective: We aimed to determine the prevalence of PD in Kilifi County, Kenya within the Kilifi Health and Demographic Surveillance System and evaluate the performance…
  • 2026 International Congress

    Feasibility study of a portable medical device, the Neuromotor pen, as a screening tool for Parkinson’s disease in a rural northern Tanzania

    I. Terry, T. Neal, R. Haggie, W. Eliamini, S. Linus, M. Dekker, S. Urasa, D. Mushi, R. Zietsma, D. Bramwell, C. Papasavvas, C. Nye, R. Walker, C. Dotchin (Newcastle, United Kingdom)

    Objective: To evaluate the feasibility and acceptability of the Neuromotor pen (NMP) as a screening tool for Parkinson’s disease in a rural Tanzanian population. Background:…
  • 2026 International Congress

    Dopaminergic reconfiguration of an inverted network hierarchy in Parkinson’s disease

    Z. Zhang, T. Feng (Beijing, China)

    Objective: To determine how acute dopaminergic treatment reshapes large-scale brain network organization in Parkinson’s disease (PD). Background: Dopamine replacement reliably improves motor symptoms in PD,…
  • 2026 International Congress

    Reconfiguration of Structural-Functional Coupling Associated with Clinical Features and 5-Year Progression in Parkinson’s Disease: A Cross-sectional and Longitudinal Study

    Y. Li, P. He, L. Wang, K. Nie (Guangzhou, Guangdong Province, China)

    Objective: This study aimed to characterize Structural–functional coupling (SFC) reorganization in Parkinson’s disease (PD), examine its associations with motor and cognitive performance, and assess whether…
  • 2026 International Congress

    Study on the Mechanism of SIRT3 Protecting Parkinson’s disease by Regulating Mitophagy

    NW. Hu, M. Zhang, HM. Cao, QM. Qu (Xi'an, China)

    Objective: To clarify the protective effect of SIRT3 on Parkinson's disease (PD) and the molecular mechanism by which it regulates mitophagy. Background: PD involves movement…
  • 2026 International Congress

    Peripheral Inflammatory Markers and Clinical Correlations in Parkinson’s Disease Patients Carrying LRRK2 G2385R and R1628P Variants

    HX. Ding, TS. Toh, NJ. Zulkefli, NS. Zulhaimi, AN. Khairul Anuar, JW. Hor, YW. Tay, IX. Kong, YC. Pang, R. Rajasuriar, SY. Lim, AH. Tan, LC. Lit (Kuala Lumpur, Malaysia)

    Objective: To investigate plasma cytokines and chemokines with clinical correlations between Parkinson’s disease (PD) patients carrying LRRK2 p.G2385R and/or p.R1628P variants, idiopathic PD (iPD), and healthy controls.…
  • « Previous Page
  • 1
  • …
  • 185
  • 186
  • 187
  • 188
  • 189
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley